News, Updates and Press Releases

June 15, 2021

Sona Discontinues Clinical Trial for COVID-19 Rapid Saliva Test

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021...

Read more

May 20, 2021

Sona Nanotech Approved for Funding Support to Develop a Bovine Tuberculosis Rapid Test

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021...

Read more

April 22, 2021

Sona to Commence Clinical Trial for COVID-19 Rapid Saliva Test

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021...

Read more

April 13, 2021

Sona Secures Clinical Trial Authorization and Hospital Partner

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021...

Read more

April 12, 2021

Sona Establishes an At-the-Market Common Share Offering

Halifax, Nova Scotia—(Newsfile Corp. – April 9, 2021) –Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona“) a...

Read more

March 23, 2021

Sona Announces Filing of Preliminary Short Form Base Shelf Prospectus

March 23, 2021 – Halifax, Nova Scotia – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona“) a...

Read more

December 31, 2020

Sona Nanotech Receives CE Mark Approval for its Rapid COVID-19 Antigen Test

December 31, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

December 16, 2020

Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26m in Gross Proceeds

December 16, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

December 10, 2020

Sona Nanotech Comments on Market Activity

December 10, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

December 8, 2020

Sona Nanotech $2m Private Placement Financing Fully Subscribed

December 3, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

December 3, 2020

Sona Nanotech Arranges Private Placement Financing and Appoints EU Agent for Application for CE Mark

December 3, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

November 30, 2020

Sona Nanotech Provides Corporate Update

November 30, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid,...

Read more